Upstream Bio, Inc. Common Stock (UPB) is a publicly traded Healthcare sector company. As of May 21, 2026, UPB trades at $8.40 with a market cap of $463.11M and a P/E ratio of -3.12. UPB moved +4.61% today. Year to date, UPB is -67.81%; over the trailing twelve months it is -7.89%. Its 52-week range spans $5.14 to $33.68. Analyst consensus is strong buy with an average price target of $45.00. Rallies surfaces UPB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Upstream Bio, Inc. Common Stock (UPB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. UPB moved +4.61% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $8.40 |
| Market Cap | $463.11M |
| P/E Ratio | -3.12 |
| EPS | $-2.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.68 |
| 52-Week Low | $5.14 |
| Volume | 526.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.85M |
| Net Income | $-143.44M |
| Gross Margin | 0.00% |
8 analysts cover UPB: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.00.